The proposed liberalisation of the mining and minerals sector is an assault on the rightful owners of the land and its resources. Tribal and indigenous communities across the world have been asserting their rights to the mineral wealth often found under the land they own or possess or have traditional rights to. They have been historically denied even a share of that huge wealth, leave alone legal rights of ownership. Under...

Pawar’s Report Card The Negatives     Per capita availability of cereals and pulses has fallen in last eight years     No improvement in irrigation, 60% of agriculture still dependent on monsoons     Farmers growing cereals, sugarcane, oilseeds and pulses assured higher MSP, but majority don't benefit     Production up, but not productivity. Farmer suicides are on the rise.     Poor market advisory on exports being misused to buy cheaply from farmers and make Profits overseas     Pawar...

The same full page appeared twice in three years, the first time as news, the second time as an advertisement “Not a single person from the two villages has committed suicide.” Three and a half years ago, at a time when the controversy over the use of genetically modified seeds was raging across India, a newspaper story painted a heartening picture of the technology's success. “There are no suicides here and people...

With the elderly likely to constitute a quarter of India's population by 2050, there is need for a publicly-funded, universal scheme that will overcome destitution among the aged India's social security system is woefully inadequate, when compared even to those in third world economies with no higher per capita incomes. Some States in India have fairly comprehensive social security schemes — notably Kerala, also West Bengal and Tamil Nadu — but...

Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...